Are you confident selecting between available therapies for hemophilia A? Over the past few decades, the care for patients with hemophilia A has drastically improved, while also becoming more complex, with the advent of new therapeutic options for this challenging disease. This educational activity reviews FDA-approved and investigational products used for this disease and the corresponding data for these agents.

Jordan A. Shavit, M.D., Ph.D. Medical Oncologist, Sarcoma Oncology Center Santa Monica, CA Medical Advisor, Hemophilia Foundation of Southern California Pasadena, CA Medical Director, Orthopaedic Hemophilia Treatment Center, Los Angeles, CA

Doris Quon, MD, PhD. Associate Professor of Pediatrics  Division of Pediatric Hematology/Oncology, University of Michigan Medical School CS Mott Children’s Hospital, Ann Arbor, MI

Click here to view this activity:

https://spirelearning.realcme.com/learner/course/2733